1 Article by Solimary García-Hernández
Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.
International journal of medicinal mushrooms – January 01, 2025
Summary
In Brazil, psilocybin mushrooms pose a remarkably low health risk compared to other substances. Analyzing data from over 112,000 drug-related medical cases revealed that only 13 involved psilocybin, with no fatalities. This highlights the potential for safe therapeutic use and calls for informed regulatory discussions on psilocybin access.
Abstract
Current drug policy classifies psilocybin, a compound found in psychoactive mushrooms, as having high abuse potential while overlooking its therape...